Lin, Tianlai
Zhang, Xinjue
Gong, Jianbing
Tan, Rundong
Li, Weiming
Wang, Lijun
Pan, Yingxia
Xu, Xiang
Gao, Junhui
Funding for this research was provided by:
Department of Critical Care Medicine, Quanzhou First Hospital Affiliated to Fujian Medical University
Shanghai Nuanhe Brain Technology Co., Ltd, China
Shanghai Biotecan Pharmaceuticals Co., Ltd, China
Article History
Received: 24 February 2022
Accepted: 21 April 2023
First Online: 4 May 2023
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations.All experimental protocols were approved based on the ethical standards of the Clinical Research Ethics Committee of the Department of Critical Care Medicine, Quanzhou First Hospital affiliated with Fujian Medical University, China. The approve number is No.188 [2020].The dataset supporting the conclusions of this article is the Medical Information Mart for Intensive Care version III (MIMIC-III) version 1.4 [CitationRef removed]. The databases are publicly deidentified; thus, informed consent and approval from the Institutional Review Board were waived. Our access to the database was approved after completion of the collaborative institutional training initiative (CITI program) web-based training course, “Data or Specimens Only research” (Record ID:31529575).More details are available at ExternalRef removed.
: Not applicable.
: The authors declare no competing interests.